Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GH Research PLC(GHRS) | 4,858,994 | 6,443,940 | +1,584,946 | $34.01M | $71.08M | 25.45% | +$37.06M |
| Merus N V | 1,580,841 | 1,568,841 | -12,000 | $66.47M | $66.03M | 23.65% | -$441.8K |
| Protagonist Therapeutics Inc | 0 | 733,014 | +733,014 | $0 | $35.45M | 12.69% | +$35.45M |
| Stoke Therapeutics, Inc.(STOK) | 5,187,191 | 5,291,929 | +104,738 | $57.21M | $35.19M | 12.60% | -$22.02M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,257,795 | 3,215,722 | +1,957,927 | $15.32M | $24.34M | 8.72% | +$9.02M |
| Allogene Therapeutics Inc | 10,874,723 | 11,057,009 | +182,286 | $23.16M | $16.14M | 5.78% | -$7.02M |
| C4 Therapeutics, Inc.(CCCC) | 6,852,744 | 7,098,133 | +245,389 | $24.67M | $11.36M | 4.07% | -$13.31M |
| TScan Therapeutics, Inc.(TCRX) | 5,357,347 | 5,357,347 | 0 | $16.29M | $7.39M | 2.65% | -$8.89M |
| Precision BioSciences, Inc.(DTIL) | 766,051 | 766,051 | 0 | $2.92M | $3.65M | 1.31% | +$735.4K |
| iBio, Inc.CON NEW(IBIO) | 862,279 | 862,279 | 0 | $2.11M | $3.47M | 1.24% | +$1.35M |
| Passage Bio, Inc.(PASG) | 9,256,953 | 9,256,953 | 0 | $5.25M | $3.27M | 1.17% | -$1.98M |
| Upstream Bio, Inc.(UPB) | 240,042 | 219,247 | -20,795 | $3.95M | $1.34M | 0.48% | -$2.60M |
| Neuphoria Therapeutics Inc | 45,806 | 45,806 | 0 | $157.1K | $263.8K | 0.09% | +$106.7K |
| Design Therapeutics, Inc.(DSGN) | 0 | 65,954 | +65,954 | $0 | $254.6K | 0.09% | +$254.6K |
| Allakos Inc | 3,628,144 | 0 | -3,628,144 | $4.39M | $0 | — | -$4.39M |
| Caribou Biosciences, Inc.(CRBU) | 680,189 | 0 | -680,189 | $1.08M | $0 | — | -$1.08M |
| Centessa Pharmaceuticals PlcADS | 17,400 | 0 | -17,400 | $291.4K | $0 | — | -$291.4K |
| Keros Therapeutics, Inc.(KROS) | 544,001 | 0 | -544,001 | $8.61M | $0 | — | -$8.61M |
| Repare Therapeutics Inc | 79,176 | 0 | -79,176 | $103.7K | $0 | — | -$103.7K |
| Vor Biopharma Inc.(VOR) | 637,218 | 0 | -637,218 | $707.3K | $0 | — | -$707.3K |